Bispecific T-Cell Engagers (BiTEs) as Treatment of B-Cell Lymphoma UNDERSTANDING THE PATHWAY

Source: Journal of Clinical Oncology - Category: Cancer & Oncology Authors: Tags: Understanding the Pathway Source Type: research

Related Links:

The cover image is based on the Clinical MessageChronic lymphocytic leukemia with progressive anemia secondary to development of composite lymphoma by Habib Moshref Razavi, James England, Jeffrey Craig et al.,https://doi.org/10.1002/ccr3.2656.
Source: Clinical Case Reports - Category: General Medicine Authors: Tags: FRONT COVER Source Type: research
Major diagnosis for mediastinal and abdominal lymphadenopathy is lymphoma and tuberculosis. Spontaneous remarkable evolution should discuss viral infection on the condition that no corticosteroids have been taken before as they could magically improve an authentic lymphoma. Trial of antituberculosis treatment that is used in some cases could lead to a misdiagnosis as the viral ‐infected patient can spontaneously heal as it is described in this case. AbstractMajor diagnosis for mediastinal and abdominal lymphadenopathy is lymphoma and tuberculosis. Spontaneous remarkable evolution should discuss viral infection on the con...
Source: Clinical Case Reports - Category: General Medicine Authors: Tags: CLINICAL IMAGE Source Type: research
ConclusionsCommon clinical variables coupled with vertebral body height are more predictive of first cycle MTX CL than BSA, alternate body size descriptors, and commonly used kidney function equations.
Source: Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy - Category: Drugs & Pharmacology Authors: Tags: ORIGINAL RESEARCH ARTICLE Source Type: research
This study is a multicenter, open-label trial to examine the effectiveness and safety of transplantation with reduced-intensity conditioning (RIC) for patients under 20 years old with relapsed or refractory ALCL. We defined RIC as the administration of fludarabine (30 mg/m2/day) for five days plus melphalan (70 mg/m2/day) for two days and total body irradiation at 4 Gy, followed by allogeneic hematopoietic stem cell transplantation. PMID: 32099255 [PubMed - in process]
Source: Acta Medica Okayama - Category: General Medicine Tags: Acta Med Okayama Source Type: research
Abstract The World Health Organization 2016 edition assigned anaplastic lymphoma kinase (ALK) rearrangement-associated renal cell carcinoma (ALK-RCC) as an emerging renal tumor entity. Identifying ALK-RCC is important because ALK inhibitors have been shown to be effective in treatment. Here, we report the case of a 14-year-old young man with ALK-RCC. Computed tomography revealed a well-demarcated 5.3-cm enhancing mass at the upper pole of the left kidney. There was no further history or symptoms of the sickle-cell trait. The patient underwent left radical nephrectomy. Pathologically, the mass was diagnosed as an u...
Source: Yonsei Medical Journal - Category: Universities & Medical Training Authors: Tags: Yonsei Med J Source Type: research
THURSDAY, Feb. 27, 2020 -- In a EuroNet Pediatric Hodgkin Lymphoma Group guideline, published in the February issue of HemaSphere, recommendations are presented regarding salvage therapy for pediatric patients with first relapse or refractory (R/R)...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
CONCLUSIONS: Our meta-analysis provided no overall evidence of an increased risk for both NHL and MM in subjects occupationally exposed to glyphosate. In secondary analyses we detected a small increase in risk for the category with highest level of exposure as well as for DLBCL. The evidence of publication bias suggests caution in the interpretation of the results. PMID: 32096774 [PubMed - in process]
Source: Medicina del Lavoro - Category: Occupational Health Tags: Med Lav Source Type: research
Conclusion: HIV-HL with BM involvement identifies a very high-risk subpopulation in the post-ART era.
Source: JAIDS Journal of Acquired Immune Deficiency Syndromes - Category: Infectious Diseases Tags: Epidemiology Source Type: research
Publication date: Available online 27 February 2020Source: Clinical Lymphoma Myeloma and LeukemiaAuthor(s): Joanna M. Rhodes, Vincent LoRe, Anthony R. Mato, Elise A. Chong, Jacqueline C. Barrientos, James N. Gerson, Stefan K. Barta, Daniel J. Landsburg, Sunita Dwivedy Nasta, Jakub Svoboda, Alison W. Loren, Stephen J. Schuster
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research
Publication date: Available online 27 February 2020Source: Clinical Lymphoma Myeloma and LeukemiaAuthor(s): Arafat Ali Farooqui, Aqsa Ashraf, Talha Bin Farooq, Ahmad Anjum, Saif ur Rehman, Arshia Akbar, Abraham Kanate, Robert Dean, Malik Qistas Ahmed, Muhammad Junaid Tariq, Shaha Nabeel, Muhammad Salman Faisal, Faiz Anwer
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research
More News: Cancer & Oncology | Lymphoma